Japanese researchers have identified a new seed of the amyloid beta protein. The discovery could lead to early-stage therapy for the neurodegenerative disease.
According to The Japan Times, Japan scientists have identified clusters of protein believed to trigger Alzheimer’s disease.
The discovery involves a new seed of the amyloid beta protein. Researchers say it could lead to early-stage therapy for the neurodegenerative disease.
The finding was reported on July 21, 2026.